Morphine in Myocardial Infarction: Delay in Platelet Inhibition due to Morphine Administered to Patients Presenting with Acute Coronary Syndrome ABSTRACT Background:The American College of Cardiology Foundation/American Heart Association Task Force recommends morphine for patients with ST-elevation myocardial infarction and for patients undergoing primary percutaneous coronary intervention (PPCI). A drug-to-drug interaction between morphine and the preferred […]
You are browsing archives for
Tag: myocardial infarction
Tyler McKinnon: PCSK9 as a Biomarker for...
PCSK9 as a Biomarker for Cardiovascular Risk ABSTRACT Background: Proprotein convertase subtilisin/kexin 9 (PCSK9) is a protein that prevents low-density lipoprotein (LDL) clearance from plasma through degradation of low-density lipoprotein receptors (LDL-R). Mutations that up- or down-regulate PCSK9 have been shown to affect risk of cardiovascular disease independently of plasma LDL level. In light of […]
Natasha Ludwig: Concern for Myocardial I...
Concern for Myocardial Infarction Risk Associated with Proton Pump Inhibitor Use in Patients With No Underlying Cardiovascular Disease ABSTRACT Background: Proton pump inhibitors (PPIs) are the drugs of choice when it comes to the treatment of dyspepsia and gastroesophageal reflux disease (GERD). Recently, the FDA issued a warning regarding concomitant use of omeprazole, a PPI, […]
Matthew W. Barton: Increased Cardiac Eve...
Increased Cardiac Events with Use of Supplemental Oxygen Therapy for Adult Patients Suffering From Uncomplicated STEMIs ABSTRACT Background: Although providers have been using supplemental oxygen therapy in the treatment of myocardial infarction for over 100 years, there are currently no current guidelines established for the treatment of normoxic patients. Research has shown possible worsened outcomes […]